FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns new medicinal preparations, be more exact to agents of contrasting of internal organs, and can be used in radial diagnostics at an angiography, computer tomography and a lymphography. The radiopaque agent (ROA) represents an oil contrast agent consisting from diiodoethyl aether of linoleic acid with addition of 5% of aether aethylicus of initial linoleic acid. The iodine maintenance in it makes 48%, its density 1.18 (at 20°C), viscosity 15.2 cP (at 20°C), and providing good radiopaque properties.
EFFECT: creation of the radiopaque agent possessing moderate allergenic action.
| Title | Year | Author | Number |
|---|---|---|---|
| X-RAY CONTRASTING AGENT | 2005 |
|
RU2287346C2 |
| RADIOPAQUE PREPARATION | 2011 |
|
RU2448732C1 |
| MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
| METHOD FOR PREPARING BIOLOGICALLY ACTIVE COMPLEX AND BIOLOGICALLY ACTIVE PROTEIN-POLYPEPTIDE COMPLEX | 2010 |
|
RU2428196C1 |
| PHARMACOLOGICALLY ACTIVE SUBSTANCE OF ORGANISM-PROTECTION MATERIAL, METHOD OF PREPARATION THEREOF, AND THERAPEUTIC APPLICATION | 1990 |
|
RU2104704C1 |
| METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
| IMMOBILISED BACILLUS LICHENIFORMIS BACTERIA PRODUCED SUBTILISIN SHOWING THROMBOLYTIC AND ANTICOAGULANT PROPERTIES | 2008 |
|
RU2416643C2 |
| COMPLEX CONNECTION OF 5-HYDROXY-3,6-DIMETHYLURACYL WITH SUCCINIC ACID EXHIBITING MEMBRANE-STABILIZING ACTIVITY AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2631238C1 |
| APPLICATION OF K-252A DERIVATIVES TO TREAT DISORDERS OF PERIPHERAL OR CENTRAL NERVOUS SYSTEMS AND EXCESSIVE CYTOKINE OUTPUT | 1997 |
|
RU2183959C2 |
| METHOD OF TREATING MALIGNANT GASTRIC AND DUODENAL TUMOURS | 2010 |
|
RU2436605C1 |
